US Market Research

US Market Research

What Happened in November 2024.

Friday July 17, 2026

Jul 17, 2026
∙ Paid

Be honest.

Who had XBI goes up today on their bingo card?

Japan and China fell over night. Mercifully for Koreans, Korea is on Holiday today. Numerous FOMC voters proclaimed their strong stance on murdering inflation. The 30Yr T is still above 5%.

US Future puked, QQQ was down over 2% within minutes of open and XBI ended up 1.5% anyways.

Miraculous, right?

If you look at XBI over the last year what do you see? The time-frame appears to show two things. (1) XBI is inversely correlated to interest rates and (2) the recent FDA change is good for biotechs.

On the surface this leads to a possible conclusion that interest rate cuts might be a headwind for biotechs. Or that we might be due for a retracement to the market. But, as each FOMC member made comments the XBI just chugged along.

Weird.

Let’s zoom out.

This gives a better view. I have charted since XBI reindexed. Prior to that change you can not really make any comparisons. Repeat you should not compare the XBI before the reindexing to after the reindexing. If you don’t know what I am talking about here ask your friendly LLM or read here.

Biotechs (pharma in general) began to sell off when Trump nominated RFK Jr and the market dragged the sector behind until recently. The recent year’s growth is just an Uma Thurman joke.

Prior to the recent FDA news the XBI, IWM and QQQ were all basically even money again. No one was winning the race

The only thing now standing out is the FDA news. What does this mean going forward considering interest rates really do need to rise unless PCE somehow has fallen off a cliff.

It means I can continue to hedge macroeconomic news without paying the illiquidity premium embedded in XBI options.

— AJ

DISCLAIMER: DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Our website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Past performance is not indicative of future results. The material contained on this page is intended for informational purposes only. GravityAnalytica.com is wholly-owned by Gravity Analytica, LLC. Our website is not an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content of our website and/or newsletter is not provided to any individual with a view toward their individual circumstances. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained on our website is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. We reserve the right to buy or sell shares of any company mentioned on our website or in our newsletter at any time. We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.
The company or individuals affiliated may hold positions or may enter into, or exit, positions on any equities at any time. This website and materials found on this website, or in any communication, are meant for individuals of eighteen (18) years of age or older and are not suitable for younger audiences. Materials and information provided on this website and in any communications with or from Gravity Analytica LLC, it’s employees or affiliates, are for personal education use by subscribers and may be not be used in any regard in competition with this website or any other product or service offered by Gravity Analytica LLC. Past results do not predict future returns. IF YOU DO NOT AGREE WITH THE TERMS OF THIS DISCLAIMER, PLEASE EXIT THIS SITE IMMEDIATELY. PLEASE BE ADVISED THAT YOUR CONTINUED USE OF THIS SITE OR THE INFORMATION PROVIDED HEREIN SHALL INDICATE YOUR CONSENT AND AGREEMENT TO THESE TERMS.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 Gravity Analytica Capital LLC · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture